This is an Indefinite Delivery Contract (IDC) awarded by the National Acquisition Center, which is a part of the Department of Veterans Affairs (VA), to Zydus Pharmaceuticals (USA) Inc. The contract is for the supply of Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors, including drugs such as Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin, to the VA, Bureau of Prisons, and Indian Health Service. The contract has a one-year base period with four one-year option periods, and the total ceiling value is $113,797,620.00. The contract aims to ensure an uninterrupted supply of these pharmaceutical products, which are to be distributed through the VA's Pharmaceutical Prime Vendor Programs. The contract was awarded on a single award basis, with no set-aside designation. The products will be delivered to the VA facility in Hines, Illinois.
The original solicitation, Request for Proposal (RFP) 36E79723R0037, was issued electronically on October 17, 2023, with a due date of October 31, 2023. The solicitation sought offers for an estimated annual requirement of 45,519,048 tablets of DPP-4 Inhibitors, with the awarded vendor required to offer all commercial package sizes except unit dose at the same price per tablet regardless of strength or package size. The NAICS code for this procurement is 325412, and the goods fall under PSC code 6515 for pharmaceutical preparations.
Generated 11/21/24, 9:05 AM